NCT02165618|Completed
Rationalisation of Polypharmacy by the Geriatric Consultation Team
RASP-GCT
Loading search results
RASP-GCT
Sponsor study identifier
interventional
60
1 country
1
Study Start
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2014
Actual (reported)Study Completion
February 2014
Actual (reported)Polypharmacy is a common problem in elderly, leading among others to increased adverse drug events. The aim of this pilot study was to evaluate whether a systematic medication evaluation by a geriatric consultation team using the RASP (Rationalisation of drugs on admission by an adjusted STOPP\*-list in older patients) list could reduce inappropriate prescribing for elderly admitted patients, admitted to non-geriatric departments. (\* = Screening Tool of Older Persons' potentially inappropriate Prescriptions)
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2014
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
February 2014
Actual (reported)February 2014
Actual (reported)May 26, 2014
Actual (reported)June 17, 2014
Actual (reported)Number of medication-related recommendations by the geriatric consultation team.
The number was ascertained at time of discharge from the ward, taking into account an average hospital stay of 14 days.
Number of potentially inappropriate drugs at discharge, as identified by the RASP list.
The number was ascertained at time of discharge from the ward, taking into account an average hospital stay of 14 days.
Number of drugs at discharge, relative to the drugs on admission.
The number was ascertained at time of discharge from the ward, taking into account an average hospital stay of 14 days.
Acceptance rate of the GCT interventions by the treating physician.
Up to 72 hours after the GCT had given its recommendations.
In a before phase, data on how the GCT operated (i.e. good clinical practice) was gathered.
Medication review, based on but not limited to the RASP list
Systematic approach: 1. Medication reconciliation 2. Applying the RASP list 3. Expert review (not based on the RASP list) 4. Multidisciplinary discussion
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University Hospitals Leuven
Leuven, Flemish Brabant, 3000, Belgium
Van der Linden L, Hias J, Dreessen L, Milisen K, Flamaing J, Spriet I, Tournoy J. Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT). BMC Geriatr. 2018 Jul 3;18(1):155. doi: 10.1186/s12877-018-0843-y.
Lorenz R Van der Linden, PharmD
Universitaire Ziekenhuizen KU Leuven
Johan Flamaing, MD, PhD
Universitaire Ziekenhuizen KU Leuven
Jos Tournoy, MD, PhD
Universitaire Ziekenhuizen KU Leuven
60 participants (actual enrollment reported by the registry).
First Submitted
May 26, 2014
First Posted
June 17, 2014
Study Start
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
Alleviating Geriatric Inpatients' Medication-related Iatrogenesis
Contact the study team to confirm eligibility.
Primary Completion
February 2014
Actual (reported)Study Completion
February 2014
Actual (reported)Last Updated
June 17, 2014
Record last verified: 2014-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: